Neuronetics, Inc. Income Statement
STIM|8 years of annual SEC 10-K data (FY2018-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
Neuronetics, Inc. reported $71M in revenue and $30M in net loss for FY2025. Revenue has grown at a 11.1% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.07 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.3M | $65.2M | $55.3M | $49.2M | $62.7M | $52.8M | $12.7M | $34.2M |
| Cost of Revenue | $19.6M | $15.5M | $11.7M | $11.6M | $15.4M | $12.4M | $9.6M | $6.6M |
| Gross Profit | $51.7M | $49.7M | $43.7M | $37.7M | $47.3M | $40.3M | $30.8M | $27.6M |
| SG&A Expense | $25.4M | $25.5M | $25.6M | $18.2M | $17.5M | $13.7M | $8.6M | $6.9M |
| R&D Expense | $9.5M | $9.3M | $7.9M | $9.2M | $13.7M | $8.2M | $7.9M | $8.2M |
| Operating Income | -$30.6M | -$35.1M | -$27.6M | -$22.3M | -$26.9M | -$19.8M | -$13.6M | -$9.3M |
| Interest Expense | $4.8M | $4.3M | $4.0M | $4.5M | $3.7M | $3.7M | $2.8M | $1.8M |
| Net Income | -$30.2M | -$37.2M | -$31.2M | -$27.5M | -$29.0M | -$24.1M | -$16.1M | -$11.2M |
| EPS (Basic) | -$1.05 | -$1.38 | -$1.22 | -$1.46 | -$1.58 | - | - | - |
| EPS (Diluted) | -$1.05 | -$1.38 | -$1.22 | -$1.46 | -$1.58 | -$2.69 | -$86.34 | -$76.95 |
| Shares Outstanding | 55.7M | 29.1M | 27.3M | 26.4M | 19.1M | 18.6M | 17.7M | 231.0K |
| Gross Margin | 72.5% | 76.3% | 78.9% | 76.5% | 75.4% | 76.4% | 242.0% | 80.7% |
| Operating Margin | -42.8% | -53.8% | -49.8% | -45.3% | -43.0% | -37.6% | -106.9% | -27.3% |
| Profit Margin | -42.3% | -57.0% | -56.4% | -55.8% | -46.4% | -45.7% | -126.2% | -32.8% |